Drug Database
AM

amoxicillin + clavulanic acid (Bactovan)

✓ Approved

Bharat Serums and Vaccines Limited · 小分子 · 小分子

什么是 amoxicillin + clavulanic acid?

amoxicillin + clavulanic acid 是一种小分子,由Bharat Serums and Vaccines Limited研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名Bactovan
公司Bharat Serums and Vaccines Limited
药物类别小分子
给药途径Injectable (Others)
状态Approved

治疗适应症

amoxicillin + clavulanic acid 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsStreptococcal infection✓ Approved

相关研究文献

PubMedMolecules (Basel, Switzerland)2026-11-17

RETRACTED: Mohammadi et al. Removal of Amoxicillin from Aqueous Media by Fenton-like Sonolysis/H2O2 Process Using Zero-Valent Iron Nanoparticles. Molecules 2022, 27, 6308.

Mohammadi Leili L, Kamani Hossein H, Asghari Abolfazl A, Mohammadpour Amin A et al.

The journal retracts the article titled "Removal of Amoxicillin from Aqueous Media by Fenton-like Sonolysis/H2O2 Process Using Zero-Valent Iron Nanoparticles" [...].

PMID 43041160
阅读全文 →
PubMedClinical and molecular hepatology2026-11-17

Integrated metabolomics reveals nervonic acid-associated immunometabolic.

Xu Yunfeng Y, Xu Da D, Zhou Lina L, Zhang Ze Z et al.

Hepatocellular carcinoma (HCC) exhibits profound metabolic heterogeneity, yet the functional lipid metabolites driving tumor progression and immune microenvironment remodeling remain insufficiently defined. This study aimed to construct a metabolomic atlas of HCC and identify clinically relevant metabolic vulnerabilities. Untargeted metabolomic profiling was performed in 91 paired HCC and adjacent non-tumor tissues. Integrated metabolomic, transcriptomic, clinicopathological, and immune analyses characterized metabolic heterogeneity. Nervonic acid was evaluated in HCC cells, immunocompetent and immunodeficient mouse models, and knockdown and rescue experiments targeting ATP citrate lyase (ACLY). HCC showed extensive metabolic remodeling with limited metabolite-gene concordance. Clustering identified four metabolomic subtypes. The high-risk subtype MS1 exhibited poor prognosis, pronounced very-long-chain fatty acid remodeling, and immunosuppressive features. Nervonic acid, a very-long-chain monounsaturated fatty acid, was enriched in MS1, increased in HCC tissues, and associated with unfavorable survival. It promoted HCC cell proliferation, migration, invasion, and tumor growth. In immunocompetent models, nervonic acid reduced CD8+ T-cell infiltration and increased M2-like macrophage enrichment. Exploratory CD8 depletion suggested attenuation of the nervonic acid-associated tumor growth increment. Coordinated lipid remodeling included altered free fatty acid composition, enhanced fatty acid uptake, increased cholesterol abundance, and changes in membrane lipid order. Nervonic acid induced an ACLY-centered lipogenic program; in HCC cells, ACLY knockdown attenuated malignant phenotypes and lipid accumulation, and ACLY rescue restored these responses. Nervonic acid marks an aggressive HCC subtype with distinct immune features. Knockdown and rescue in HCC cells implicate ACLY in lipid remodeling. The prognostic value of tumor nervonic acid requires independent validation.

PMID 43041060
阅读全文 →
PubMedJournal of pediatric gastroenterology and nutrition2026-11-17

Ileal bile acid transporter inhibitors.

Di Buduo Ersilia E, Crudele Lucilla L, Cantatore Salvatore S, Moschetta Antonio A

Pediatric cholestatic liver diseases, such as Alagille syndrome and progressive familial intrahepatic cholestasis, are rare genetic disorders characterized by impaired bile flow, systemic bile acid accumulation, and debilitating pruritus. Historically managed with supportive care or invasive surgical interventions, the therapeutic landscape has recently expanded with the introduction of ileal bile acid transporter (IBAT) inhibitors. These luminal, ileum-targeted agents block bile acid reabsorption, thereby increasing fecal bile acid excretion and effectively reducing the systemic bile acid pool to relieve pruritus. However, this pharmacological blockade also attenuates the intestinal farnesoid X receptor (FXR)-fibroblast growth factor 19 (FGF19) feedback loop, leading to a compensatory increase in hepatic bile acid synthesis. Consequently, the clinical efficacy and safety of IBAT inhibitors are heavily dependent on a sufficiently preserved enterohepatic bile flow and canalicular export capacity. When luminal bile acid delivery is impaired, therapeutic benefits diminish, and the unchecked compensatory synthesis may contribute to hepatocyte stress and elevated transaminases. Thus, optimizing the use of these therapies will require a shift from broad disease-label indications toward precision, genotype- and physiology-informed patient selection, utilizing non-invasive biomarkers to assess target engagement and guide clinical management.

PMID 43042691
阅读全文 →
PubMedClinical hemorheology and microcirculation2026-11-17

Uric acid/HDL-cholesterol ratio and uric acid/mean erythrocyte aggregation ratio in subclinical carotid atherosclerosis.

Caimi Gregorio G, Lo Presti Rosalia R, Urso Caterina C, Brucculeri Salvatore S et al.

Background and aimSeveral literature studies have highlighted an association between elevated serum acid levels and cardiovascular diseases, including atherosclerotic disease, with also a link in case of normal uricemia values; in relation to this relation, in this new study regarding our cohort of subjects with subclinical carotid atherosclerosis, we have examined the uric acid/HDL-C ratio and the uric acid/mean erythrocyte aggregation ratio.MethodsOur retrospective, cross-sectional, and explorative study population includes 100 subjects (43 men and 57 women) with subclinical carotid atherosclerosis; in this population we have evaluated: serum uric acid, HDL-Cholesterol, mean erythrocyte aggregation, uric acid/HDL-C ratio (UHR) and uric acid/mean erythrocyte aggregation ratio (UEAR).ResultsFrom the obtained data we observed that only UHR is able to discriminate the subgroups of the whole cohort assembled according to the number of cardiovascular risk factors and according to the degree of insulin resistance evaluated with some surrogate indices; moreover, the UHR is positively correlated with each index of insulin resistance.ConclusionThese data confirm the possible utility of UHR, and at the same time, despite the premises, the UEAR does not seam to have, at now, any particular role in this clinical condition.

PMID 43042619
阅读全文 →
PubMedInfection and drug resistance2026-11-17

Antimicrobial Resistance and Genomic Characteristics of Helicobacter pylori in Peptic Ulcer Disease: A Five-Case Series.

Fang Yunhui Y, Wang Kun K

Peptic ulcer disease is a well-established clinical manifestation of Helicobacter pylori infection. Antimicrobial resistance can compromise eradication, particularly after prior treatment. We describe a small surveillance-based case series integrating clinical history, phenotypic antimicrobial susceptibility, and genomic findings; the series was not designed to estimate population-level resistance patterns. Five patients with endoscopically documented gastric and/or duodenal ulcer and culture-confirmed H. pylori infection were identified during routine clinical microbiological surveillance from March 2023 to April 2024. Clinical data, Minimum Inhibitory Concentration (MIC)-based antimicrobial susceptibility, selected variants in resistance-related loci, virulence-associated genes, genome assembly characteristics, and a core-genome alignment-based comparative overview were analyzed descriptively; no inferential statistical testing was performed. The five patients were 25-51 years old and had endoscopically documented gastric and/or duodenal ulcers; concomitant gastritis or mucosal erosion was recorded separately. Four patients had documented prior eradication exposure, whereas treatment history was incomplete for one. All five isolates were resistant to clarithromycin and metronidazole and susceptible to levofloxacin, tetracycline, and rifampicin; two were also resistant to amoxicillin and met the study definition of multidrug resistance. All isolates carried 23S rRNA substitutions including the established clarithromycin resistance-associated A2147G substitution, whereas no gyrA resistance-associated substitution was detected. cytotoxin-associated gene A (cagA) was detected in all five isolates. Draft genome sizes ranged from 1.55 to 1.65 Mb, with GC contents of 38.54-38.82%. In the descriptive core-genome alignment-based tree, isolates 207, 318, and 221 formed a relatively close branch, whereas isolates 171 and 317 were more distinct. These genomic relationships were not interpreted as evidence of epidemiological clustering. This descriptive five-case series illustrates heterogeneous case-level antimicrobial susceptibility and genomic profiles in ulcer-associated H. pylori infection. The observations are not population-level resistance estimates, but they support the clinical value of culture-based susceptibility testing and/or validated molecular resistance detection for individualized management, particularly after prior eradication treatment.

PMID 43041343
阅读全文 →
PubMedAnimal genetics2026-11-17

ESRRA Promotes Porcine Myoblast Differentiation Through CPT1A-Mediated Fatty Acid Oxidation.

Tian Yu Y, Li Mingjun M, Meng Tao T, Wang Qinghui Q et al.

Myoblast differentiation requires coordinated transcriptional regulation and metabolic remodeling, but the signaling mechanisms that couple transcription factor activity to fatty acid-dependent energy metabolism during myogenic differentiation remain incompletely understood. Here, by integrating time-series bulk transcriptomic profiles with single-cell transcriptomic data from porcine embryonic longissimus lumborum muscle, we identified ESRRA as a candidate regulator of myoblast differentiation and validated its function in primary porcine myoblasts. ESRRA expression was progressively upregulated during myotube formation, accompanied by enhanced ESRRA regulon activity in late-stage myoblasts. Functional inhibition of ESRRA impaired MyHC-positive myotube formation, reduced myogenic marker expression, suppressed fatty acid oxidation and ATP production, and promoted lipid droplet accumulation. Activation of fatty acid oxidation with bezafibrate partially rescued the differentiation defects caused by ESRRA knockdown, indicating that ESRRA supports myogenic differentiation through fatty acid oxidation-dependent metabolic signaling. Mechanistically, CUT&Tag, CUT&RUN-qPCR, expression analysis, and rescue experiments identified CPT1A as a direct transcriptional target and functional downstream effector of ESRRA. Together, these findings define an ESRRA-CPT1A transcriptional-metabolic signaling axis that couples fatty acid oxidation to porcine myoblast differentiation, providing new insight into how metabolic signaling regulates skeletal muscle cell differentiation.

PMID 43041064
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多amoxicillin + clavulanic acid